Analytical Standards

JWH 018 is a potent synthetic cannabinoid (CB) which has been identified in smoking mixtures.

3,5-AB-CHMFUPPYCA is an analytical reference standard that is structurally similar to known synthetic cannabinoids.

5,3-AB-CHMFUPPYCA is an analytical reference standard that is structurally similar to known synthetic cannabinoids.

THJ 018 is an analog of JWH 018 where the core indole structure is substituted with an indazole base.

AB-005 is a synthetic cannabinoid (CB) built on a 1-[(1-methylpiperidin-2-yl)methyl]-indole base that is characteristic of a series of potent CBs, including AM1220, AM1241, and AM1248.

15-keto PGF1α is the initial metabolite of PGF1α via 15-hydroxy PGDH.

AM2201 is a potent synthetic cannabinoid (CB) with Ki values of 1.0 and 2.6 nM for the central CB1 and peripheral CB2 receptors, respectively.

AM2201 is a potent synthetic cannabinoid (CB) with Ki values of 1.0 and 2.6 nM for the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, respectively.

AM2201 is a potent synthetic cannabinoid (CB) with Ki values of 1.0 and 2.6 nM for the CB1 and CB2 receptors, respectively.

JWH 412 (5-hydroxypentyl) metabolite is an analytical reference standard that is structurally similar to known synthetic cannabinoids (CBs).

AM694 is a potent synthetic cannabinoid (CB) with Ki values of 0.08 and 1.44 nM for the CB1 and CB2 receptors, respectively.

CP 47,497-C8-homolog is similar to CP 47,497, a monophenol synthetic cannabinoid (CB) that potently imitates natural CBs.

15-keto Prostaglandin E2 (15-keto PGE2) is a metabolite of PGE2 formed by 15-hydroxy PGDH.

AB-CHMINACA is a cyclohexyl-substituted derivative of the indazole-based synthetic cannabinoid, AB-FUBINACA.

17-phenyl trinor Prostaglandin F2α ethyl amide (17-phenyl trinor PGF2α ethyl amide) is an F-series PG analog which has been approved for use as an ocular hypotensive drug.

UR-144 is a synthetic cannabinoid (CB) analog of JWH 018 in which the naphthalene ring is substituted with a tetramethylcyclopropyl group.

UR-144 is a potent synthetic cannabinoid (CB) that preferentially binds the peripheral CB2 receptor (Ki = 1.8 nM) over the central CB1 receptor (Ki = 150 nM).

UR-144 is a potent synthetic cannabinoid (CB) which preferentially binds the peripheral CB2 receptor (Ki = 1.8 nM) over the central CB1 receptor (Ki = 150 nM).

5-fluoro AMB metabolite 3 is an analytical reference standard that is structurally similar to known synthetic cannabinoids.

ADB-BICA is an analytical reference standard that is structurally classified as a synthetic cannabinoid.

(±)-ORG 28611 is the racemic mixture of the water soluble, full agonist of the human cannabinoid (CB) receptors central CB1 (pEC50 = 7.6; pKi = 8.9) and peripheral CB2 (pKi = 8.8).

MMB022 is an analytical reference standard that is structurally similar to known synthetic cannabinoids.

Tofisopam is a 2,3-benzodiazepine anxiolytic agent. Tofisopam exerts its pharmacological effects by selectively inhibiting phosphodiesterase (PDE) isoenzymes (with IC 50 values of 2.11μM for PDE-2A3, 1.98μM for PDE-3A, 0.42μM for PDE-4A1, and 0.92μM for PDE-10A1).

ADBICA is a synthetic cannabinoid (CB) that has recently been identified in herbal blends.